New AI Test Aims to Improve Breast Cancer Recurrence Prediction
COTA, PreciseDx, and Baptist Health South Florida to improve breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test.
Source: hitconsultant.net
Stay updated with breaking news from Transform Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COTA, PreciseDx, and Baptist Health South Florida to improve breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test.